| Literature DB >> 34291726 |
Jialiang Li1, Guangyue Li1, Yige Qi1, Yao Lu1, Hao Wang1, Ke Shi1, Dangdang Li1, Jinming Shi1, Daniel B Stovall2, Guangchao Sui1.
Abstract
ABBREVIATIONS: ARF: alternative reading frame, that is, p14ARF, or CDKN2A (cyclin-dependent kinase inhibitor 2A); β-gal: β-galactosidase; CLIP-seq: crosslinking and immunoprecipitation-sequencing; DMTF1: the cyclin D binding myb-like transcription factor 1; ESS/ESE: exonic splicing silencer/enhancer; Ex: exon; FBS: fetal bovine serum; Gluc: Gaussia luciferase; hnRNPs: heterogeneous nuclear ribonucleoproteins; In: intron; ISS/ISE: intronic splicing silencer/enhancer; PBS: phosphate-buffered saline; PCR: polymerase chain reaction; PSI: percent-splice-in; qPCR: quantitative real-time PCR; RIP: RNA immunoprecipitation; RNAseq: RNA sequencing; RT: reverse transcription; SF1: splicing factor 1; SR: serine/arginine-rich proteins; SRSF5: serine and arginine-rich splicing factor 5; TCGA: the cancer genome atlas; UCSC: University of California, Santa Cruz. WT: Wild type.Entities:
Keywords: DMTF1; SF1; SRSF5; alternative splicing; breast cancer
Mesh：
Substances：
Year: 2021 PMID： 34291726 PMCID： PMC8677014 DOI： 10.1080/15476286.2021.1947644
Source DB: PubMed Journal: RNA Biol ISSN： 1547-6286 Impact factor: 4.766